Drug
GSK3882347 clinical trials
Also written GSK3882347.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2020
How studies write it
Studies that test it under each name
Development codes
- GSK3882347
- 3
Studies by the year they started
3 studies that test it; most in 2020 (1)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses GSK3882347 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract InfectionsCompletedPhase 1GlaxoSmithKlineNCT05138822Written as GSK3882347
- Drug Interaction Assessment of GSK3882347 in Healthy Participants Aged 18 to 65 YearsCompletedPhase 1GlaxoSmithKlineNCT05760261Written as GSK3882347
- Safety, Tolerability and Pharmacokinetic Investigation of GSK3882347 in Healthy Participants.CompletedPhase 1GlaxoSmithKlineNCT04488770Written as GSK3882347